Clinical Trials Directory

Trials / Sponsors / Guangzhou Bio-gene Technology Co., Ltd

Guangzhou Bio-gene Technology Co., Ltd

Industry · 14 registered clinical trials — 11 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingClinical Study on Evaluating the Safety and Effectiveness of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refra
Relapsed/Refractory Multiple Myeloma
N/A2025-10-10
Not Yet RecruitingBCMA/GPRC5D CAR-T Therapy for Multiple Myeloma
Multiple Myeloma Refractory
EARLY_Phase 12025-10-10
Not Yet RecruitingBAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors
B Acute Lymphoblastic Leukemia/Lymphoma
EARLY_Phase 12025-10-10
Not Yet Recruitingγδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant
Leukemia, Myeloid, Acute
EARLY_Phase 12025-09-01
RecruitingClinical Study on the Safety and Preliminary Efficacy of CDH17/GUCY2C CAR-T in the Treatment of Patients With
Colorectal Cancer (CRC)
N/A2025-09-01
RecruitingClinical Study on the Safety and Efficacy of B7H3 CAR T Cells in Patients With B7H3 Positive Solid Tumors
Solid Tumors
N/A2025-08-31
RecruitingClinical Study on the Safety and Efficacy of CD19-BCMA CAR-T Cell Therapy for Connective Tissue Diseases
Connective Tissue Diseases
N/A2025-08-30
Not Yet RecruitingExosomes for Hairloss Treatment
Hair Loss
EARLY_Phase 12025-04-30
RecruitingMesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia
ITP - Immune Thrombocytopenia
N/A2025-01-10
Not Yet RecruitingBG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children
Leukemia, Acute Myeloid Leukemia
Phase 12024-04-01
RecruitingPhase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Leukemia, Myeloid, Acute
Phase 1 / Phase 22024-03-07
TerminatedClinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Relapsed or Refractory Multipl
Relapsed or Refractory Multiple Myeloma
N/A2023-09-21
WithdrawnClinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid Leukem
Acute Myeloid Leukemia
N/A2023-07-12
WithdrawnA Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma
T-Cell Acute Lymphocytic Leukemia
Phase 1 / Phase 22023-05-01